| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wahlstrom Mats | Director | C/O COHERUS BIOSCIENCES, INC., 333 TWIN DOLPHIN DRIVE, SUITE 600, REDWOOD CITY | /s/ Bryan McMichael, as Attorney-in-Fact for Mats Wahlstrom | 28 May 2025 | 0001459154 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CHRS | Common Stock | Sale | $73,881 | -99,988 | -100% | $0.7389 | 0 | 23 May 2025 | Leonard Capital, LLC | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | The reported sale transactions were effected for tax planning purposes. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7362 to $0.7448, exclusive of any fees, commissions or other expenses. The Reporting Person undertakes to provide to Coherus BioSciences, Inc., any security holder of Coherus BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. |
| F3 | The Reporting Person and his spouse are the members of Leonard Capital, LLC and therefore the Reporting Person may be deemed to have voting and dispositive power of shares held by Leonard Capital, LLC. |